However, greater numbers of mucinous ovarian cancer cases are required before this indication that preoperative serum STn levels may add predictive power to serum CA-125 levels for distinguishing ovarian cancer from benign pelvic disease and such estimates are deemed stable and accurate. This evidence concerns the gene MUC16 and mucinous ovarian cancer.